During a live event, Matthew Galsky, MD discussed neoadjuvant and adjuvant options for a patient case including nivolumab or dose-dense MVAC.

A roundup of 2025's most impactful nanomaterial innovations. From energy storage and flexible electronics to cancer treatment ...

A DAILY pill for the most common form of bladder cancer has been given the green light for NHS use. Erdafitinib, which blocks ...

Bavencio as first-line maintenance was associated with long-term efficacy in advanced urothelial carcinoma regardless of ...

Urothelium is the term for the mucous membrane that lines the urinary tract. This includes the renal pelvis, ureter, urinary ...

Study finds enfortumab vedotin + pembrolizumab significantly boosts survival in advanced urothelial carcinoma patients ...

AstraZeneca‘s IMFINZI® (durvalumab) has gained FDA approval for use in adult patients with muscle-invasive bladder cancer ...

At a time when other nations are expanding research and development, the U.S. should be strengthening its commitment, not ...

Urothelium is the term for the mucous membrane that lines the urinary tract. This includes the renal pelvis, ureter, urinary bladder and the upper part of the urethra. In the vast majority of cases, ...

The FDA approved agents in MIBC and neuroendocrine tumors and amivantamab/lazertinib continues to shine in NSCLC.